These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment. Acelajado MC; Calhoun DA Cardiol Clin; 2010 Nov; 28(4):639-54. PubMed ID: 20937447 [TBL] [Abstract][Full Text] [Related]
23. Nonadherence in patients with hypertensive emergency or hypertensive urgency. Krämer BK; Krämer RM; Benck U; Krüger B J Clin Hypertens (Greenwich); 2019 Jan; 21(1):64-66. PubMed ID: 30515939 [No Abstract] [Full Text] [Related]
24. Drug nonadherence is a common but often overlooked cause of hypertensive urgency and emergency at the emergency department. Overgaauw N; Alsma J; Brink A; Hameli E; Bahmany S; Peeters LEJ; Van Den Meiracker AH; Schuit SCE; Koch BCP; Versmissen J J Hypertens; 2019 May; 37(5):1048-1057. PubMed ID: 30480568 [TBL] [Abstract][Full Text] [Related]
25. Hypertensive Urgency in Tanzanian Adults: A 1-Year Prospective Study. Reis KG; Wilson R; Kalokola F; Wajanga B; Lee MH; Safford M; Peck RN Am J Hypertens; 2020 Dec; 33(12):1087-1091. PubMed ID: 32776154 [TBL] [Abstract][Full Text] [Related]
27. A compendium for the treatment of hypertensive emergencies. Vidt GD; Gifford RW Cleve Clin Q; 1984; 51(2):421-30. PubMed ID: 6467601 [No Abstract] [Full Text] [Related]
28. Hypertensive crisis--an overview. Kumar A; Banerjee M J Indian Med Assoc; 1997 Sep; 95(9):511-2, 527. PubMed ID: 9529586 [No Abstract] [Full Text] [Related]
29. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department. Wallbach M; Lach N; Stock J; Hiller H; Mavropoulou E; Chavanon ML; Neurath H; Blaschke S; Lowin E; Herrmann-Lingen C; Müller GA; Koziolek MJ J Clin Hypertens (Greenwich); 2019 Jan; 21(1):55-63. PubMed ID: 30515967 [TBL] [Abstract][Full Text] [Related]
30. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Williams B; Mancia G; Spiering W; Agabiti Rosei E; Azizi M; Burnier M; Clement DL; Coca A; de Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen SE; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder RE; Shlyakhto E; Tsioufis C; Aboyans V; Desormais I; J Hypertens; 2018 Oct; 36(10):1953-2041. PubMed ID: 30234752 [TBL] [Abstract][Full Text] [Related]
31. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence. Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Gulsin GS; Beech A; Marešová V; Topham PS; Stanley A; Thurston H; Smith PR; Horne R; Widimský J; Keavney B; Heagerty A; Samani NJ; Williams B; Tomaszewski M Hypertension; 2017 Nov; 70(5):1042-1048. PubMed ID: 28847892 [TBL] [Abstract][Full Text] [Related]
32. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients. Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066 [TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Nonadherence to Antihypertensive Treatment. Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Marešová V; White CMJ; Petrák O; Gulsin GS; Patel V; Rosa J; Cole R; Zelinka T; Holaj R; Kinnell A; Smith PR; Thompson JR; Squire I; Widimský J; Samani NJ; Williams B; Tomaszewski M Hypertension; 2017 Jun; 69(6):1113-1120. PubMed ID: 28461599 [TBL] [Abstract][Full Text] [Related]
34. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ; Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922 [TBL] [Abstract][Full Text] [Related]
35. How to Screen for Non-Adherence to Antihypertensive Therapy. Gupta P; Patel P; Horne R; Buchanan H; Williams B; Tomaszewski M Curr Hypertens Rep; 2016 Dec; 18(12):89. PubMed ID: 27889904 [TBL] [Abstract][Full Text] [Related]
36. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial. Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G; Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780 [TBL] [Abstract][Full Text] [Related]
37. An Electronic Adherence Measurement Intervention to Reduce Clinical Inertia in the Treatment of Uncontrolled Hypertension: The MATCH Cluster Randomized Clinical Trial. Kronish IM; Moise N; McGinn T; Quan Y; Chaplin W; Gallagher BD; Davidson KW J Gen Intern Med; 2016 Nov; 31(11):1294-1300. PubMed ID: 27255750 [TBL] [Abstract][Full Text] [Related]